Squamous Cell Carcinoma of the Hypopharynx
📧 Sign up to get email alerts when something new happens for Squamous Cell Carcinoma of the Hypopharynx.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2022-12-20Clinical Trial Update: Cetuximab & Nivolumab in Patients With Recurrent/Metastatic Head & Neck Squamous Cell Carcinoma [Phase 1, Phase 2]
A Phase 1/2 study evaluating the combination of cetuximab and nivolumab in recurrent or metastatic head and neck squamous cell carcinoma has…
-
CLINICAL_TRIALS trial_result · 2022-05-26Clinical Trial Update: Induction Chemotherapy With TP+5-FU or TP+Cetuximab Followed by Radioimmuptherapy for Locally Advanced or Not Resectable SCCHNN [Phase 2]
Phase 2 trial evaluating induction TP+5-FU or TP+cetuximab followed by radioimmunotherapy for locally advanced or unresectable squamous cell…
-
CLINICAL_TRIALS trial_result · 2020-05-12Clinical Trial Update: Erlotinib Hydrochloride and Radiation Therapy in Stage III-IV Squamous Cell Cancer of the Head and Neck [Phase 2]
Phase 2 trial evaluating erlotinib hydrochloride with radiation therapy in various Stage III-IV squamous cell carcinomas of the head and nec…
-
CLINICAL_TRIALS trial_result · 2020-05-01Clinical Trial Update: Parenteral Nutrition for Patients Treated for Locally Advanced Inoperable Tumors of the Head and Neck [Phase 3]
Phase 3 clinical trial investigating parenteral nutrition for patients treated for locally advanced inoperable head and neck squamous cell c…
-
CLINICAL_TRIALS trial_result · 2020-03-19Clinical Trial Update: Capecitabine and Lapatinib Ditosylate in Treating Patients With Squamous Cell Cancer of the Head and Neck [Phase 2]
Phase 2 clinical trial evaluating capecitabine and lapatinib ditosylate in various forms of head and neck squamous cell carcinoma has comple…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2018-08-14Clinical Trial Update: Paclitaxel and Carboplatin Before Radiation Therapy With Paclitaxel in Treating HPV-Positive Patients With Stage III-IV Oropharynx, Hypopharynx, or Larynx Cancer [Phase 2]
Phase 2 trial evaluating paclitaxel and carboplatin before radiation therapy in HPV-positive Stage III-IV oropharynx, hypopharynx, or larynx…
-
CLINICAL_TRIALS trial_result · 2016-01-27Clinical Trial Update: Adaptive, Image-guided, Intensity-modulated Radiotherapy for Head and Neck Cancer in the Reduced Volumes of Elective Neck [Phase 2]
Phase 2 trial investigating adaptive, image-guided radiotherapy with intensity-modulated radiotherapy for head and neck squamous cell carcin…
-
CLINICAL_TRIALS trial_result · 2015-05-19Clinical Trial Update: Depsipeptide in Unresectable Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck [Phase 2]
Phase 2 clinical trial update for depsipeptide in unresectable recurrent or metastatic squamous cell carcinoma of the head and neck; study c…
-
CLINICAL_TRIALS trial_result · 2015-04-15Clinical Trial Update: Lapatinib Ditosylate in Treating Patients With Metastatic or Recurrent Head and Neck Cancer [Phase 2]
A Phase 2 trial evaluating lapatinib ditosylate in patients with metastatic or recurrent head and neck cancer has been completed.
-
CLINICAL_TRIALS trial_result · 2013-01-25Clinical Trial Update: Gefitinib and Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III or Stage IV Head and Neck Cancer [Phase 1]
Phase 1 trial assessing gefitinib with radiation therapy, with or without cisplatin, for Stage III or Stage IV head and neck squamous cell c…
-
CLINICAL_TRIALS trial_result · 2013-01-24Clinical Trial Update: Intratumoral PV701 in Treating Patients With Advanced or Recurrent Unresectable Squamous Cell Carcinoma of the Head and Neck [Phase 1]
Phase 1 trial update on intratumoral PV701 for patients with advanced or unresectable recurrent squamous cell carcinoma of the head and neck…
-
CLINICAL_TRIALS trial_result · 2012-12-27Clinical Trial Update: Bortezomib With or Without Irinotecan in Treating Patients With Locally Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck [Phase 2]
Phase 2 trial evaluating bortezomib with or without irinotecan in locally recurrent or metastatic squamous cell carcinoma of the head and ne…